• linkedin
  • Increase Font
  • Sharebar

    Telemedicine making ROP screening and monitoring a viable reality

     

    Future of digital imaging

    Smartphone devices can capture high-quality images (either with or without hardware attachments), but are limited with regard to field of view. Dedicated digital fundus cameras provide the highest quality images, and “are finally evolving” in the pediatric field.

    Cost remains an issue, and will continue to limit the use and market penetration, Dr. Capone said. Ultra widefield imaging is not yet available. But any discussion on imaging would be “incomplete” without the mention of evolving optical coherence tomography (OCT) technologies, he said.

    “OCT promises to bring depth to the current two dimensional construct,” Dr. Capone said, citing the work being done on 3D techniques for analyzing vascular findings by Cynthia Toth, MD, and colleagues at Duke University.

    “There are early reports of ROP eyes imaged using both commercially available, and prototype OCT-angiography technology designed specifically for ROP” that are showing promise, he said.

    Digital health technology “can reduce healthcare costs and improve access and outcomes for infants at risk for ROP,” he said. “More than 15 years ago, I spoke about the future of telemedicine. That future is now.”

    Reference:

    1. Vartanian RJ, Besirli CG, Barks JD, et al. Trends in the Screening and Treatment of Retinopathy of Prematurity. Pediatrics.2017;139(1):e20161978

    Antonio Capone, Jr., MD

    p. 248-288-2280

    e. [email protected]

    This article is adapted from a presentation the Dr. Capone delivered at the Retina Subspecialty Day, prior to the 2017 American Academy of Ophthalmology meeting.

    Dr. Capone is an equity owner in Broadspot, FocusROP, Phoenix Technology Group, and Retinal Solutions. He also holds patents and receives royalties from Retina Solutions. He also received grants, patents/royalties, and is an advisor to other ophthalmic companies unrelated to the subject matter.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow

    var script= ' ';